We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B Turnover 17.35%
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+6.4%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$575M
AUM Growth
+$25.5M
Cap. Flow
-$9.13M
Cap. Flow %
-1.59%
Top 10 Hldgs %
68.14%
Holding
91
New
5
Increased
34
Reduced
36
Closed
2
Avg Time Held
3.3 years
Top 10 Avg Time Held
2.7 years
Top 20 Avg Time Held
2.8 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 94.85%
2 Technology 2.82%
3 Consumer Discretionary 0.77%
4 Communication Services 0.57%
5 Consumer Staples 0.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PEP icon
76
PepsiCo
PEP
$179B
$290K 0.05%
1,954
+317
+19% +$46.2K
2020 Q1
5 quarters
EOG icon
77
EOG Resources
EOG
$82.9B
$284K 0.05%
3,402
– –
2021 Q1
1 quarter
NKE icon
78
Nike
NKE
$55.1B
$278K 0.05%
+1,801
New +$242K
2021 Q2
0 quarters
TLTD icon
79
Northern Trust Morningstar Developed Markets ex-US Factor Tilt ETF
TLTD
$661M
$272K 0.05%
3,727
+35
+0.9% +$2.57K
2020 Q3
3 quarters
JNJ icon
80
Johnson & Johnson
JNJ
$616B
$251K 0.04%
+1,521
New +$252K
2021 Q2
0 quarters
BAC icon
81
Bank of America
BAC
$358B
$233K 0.04%
5,645
+50
+0.9% +$2.05K
2021 Q1
1 quarter
IWR icon
82
iShares Russell Mid-Cap ETF
IWR
$56.1B
$225K 0.04%
2,836
– –
2021 Q1
1 quarter
MCHP icon
83
Microchip Technology
MCHP
$40.1B
$215K 0.04%
2,872
– –
2021 Q1
1 quarter
QQQ icon
84
Invesco QQQ Trust
QQQ
$475B
$215K 0.04%
+608
New +$204K
2021 Q2
0 quarters
LOW icon
85
Lowe's Companies
LOW
$111B
$211K 0.04%
1,088
– –
2021 Q1
1 quarter
PM icon
86
Philip Morris
PM
$320B
$211K 0.04%
+2,126
New +$204K
2021 Q2
0 quarters
EVFM
87
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$57K 0.01%
3,333
– –
2020 Q2
4 quarters
MKC icon
88
McCormick & Company Non-Voting
MKC
$12.5B
– –
-2,256
Closed -$201K –
UBER icon
89
Uber
UBER
$144B
– –
-5,430
Closed -$296K –

Similar funds

Callan Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Callan Capital held 91 positions worth $575M, up 4.6% from $550M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Callan Capital's Q2 2021 filing shows 5 new, 34 increased, 36 reduced and 2 closed positions. Its largest new stake was Infinity Pharmaceuticals, Inc.: 121,800 shares worth $364K. The largest sale was Invesco FTSE RAFI US 1000 ETF, an estimated $3.23M.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, down from 95% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Callan Capital's largest Q2 2021 buy was Infinity Pharmaceuticals, Inc.: 121,800 shares worth $364K.
  • Callan Capital added most to Goldman Sachs ActiveBeta International Equity ETF in Q2 2021, an estimated $1.08M increase.
  • Callan Capital's biggest Q2 2021 reduction was Invesco FTSE RAFI US 1000 ETF, cutting an estimated $3.23M.
  • Callan Capital fully exited Uber in Q2 2021, selling an estimated $296K.
  • Callan Capital's ten largest holdings make up 68% of its $575M portfolio in Q2 2021.
  • Callan Capital opened 5 new positions and closed 2 in Q2 2021.
  • Callan Capital's portfolio value rose 4.6% quarter-over-quarter to $575M.

Based on Callan Capital's 13F filing for Q2 2021, filed 10 Aug 2021.